본문 바로가기

Signing of the Land Sale Contract for the Establishment of the SK Bioscience Research Institute
  • Date Created : 2021-12-27
  • Number of Views : 19
(211227)SK바이오사이언스 투자 계약 체결(01)
(211227)SK바이오사이언스 투자 계약 체결(02)
(211227)SK바이오사이언스 투자 계약 체결(03)
(211227)SK바이오사이언스 투자 계약 체결(04)
(211227)SK바이오사이언스 투자 계약 체결(05)
(211227)SK바이오사이언스 투자 계약 체결(06)
(211227)SK바이오사이언스 투자 계약 체결(01)
(211227)SK바이오사이언스 투자 계약 체결(02)
(211227)SK바이오사이언스 투자 계약 체결(03)
(211227)SK바이오사이언스 투자 계약 체결(04)
(211227)SK바이오사이언스 투자 계약 체결(05)
(211227)SK바이오사이언스 투자 계약 체결(06)

On Monday, December 27, 2021, IFEZ signed a land sale contract with SK Bioscience for the establishment of a research institute in Songdo International City. SK Bioscience plans to develop a vaccine research and development facility and build both its headquarters and research institute on Lot SR14 in the expanded Technopark complex of District 7 in Songdo International City, located at 178-3 Songdo-dong, on a site of 30,413.8 square meters. Based on its own research and development capabilities and globally recognized production capacity, SK Bioscience has contributed to strengthening Korea’s vaccine industry competitiveness through the development of its own COVID-19 vaccine and contract manufacturing.